Testing the amyloid hypothesis of Alzheimer's disease in vivo

Lancet Neurol. 2010 Apr;9(4):333-5. doi: 10.1016/S1474-4422(10)70055-7. Epub 2010 Feb 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / physiopathology*
  • Alzheimer Disease / therapy
  • Amyloid / metabolism*
  • Aniline Compounds
  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Biomarkers / metabolism
  • Brain / diagnostic imaging
  • Brain / physiopathology*
  • Genetic Predisposition to Disease
  • Humans
  • Immunization, Passive
  • Immunologic Factors / therapeutic use
  • Models, Neurological*
  • Positron-Emission Tomography
  • Thiazoles
  • Treatment Outcome

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid
  • Aniline Compounds
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Immunologic Factors
  • Thiazoles
  • bapineuzumab